Phenotypic Clinical, and Genetic Characteristics of Patients With Nontuberculosis Mycobacteria (Korean NTM)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2012 by Seoul National University Hospital
Sponsor:
Information provided by (Responsible Party):
Jae-Joon Yim, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01616745
First received: March 25, 2012
Last updated: June 11, 2012
Last verified: June 2012
  Purpose

The purpose of this study is to elucidate phenotypic, clinical, and genetic characteristics of Korean Nontuberculosis Mycobacteria (NTM) patients.


Condition
Nontuberculosis Mycobacterial Lung Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Characteristics of Patients With Nontuberculosis Mycobacteria in Korean Population

Resource links provided by NLM:


Further study details as provided by Seoul National University Hospital:

Estimated Enrollment: 500
Study Start Date: July 2011
Estimated Study Completion Date: February 2021
Detailed Description:

To elucidate phenotypic, clinical, and genetic characteristics of Korean NTM patients.

Especially, to compare body mass index, positive rate of IGRA, and CFTR mutation with general Korean population.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

persons met diagnostic criteria of NTM lung disease by ATS/IDSA on 2007

Criteria

Inclusion Criteria:

  • Persons met diagnostic criteria of NTM lung disease by ATS/IDSA on 2007

Exclusion Criteria:

  • Already on treatment for NTM lung disease
  • Appropriate exclusion of other lung diagnosis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01616745

Contacts
Contact: Jae-Joon Yim, MD 82-2-2072-2059 yimjj@snu.ac.kr
Contact: Ae-Ra Lee, MD 82-31-787-2455 drmom@paran.com

Locations
Korea, Republic of
Seoul National University Hospital Recruiting
Seoul, Korea, Republic of
Contact: Jae-Joon Yim, MD    82-2-2072-2059    yimjj@snu.ac.kr   
Contact: Ae-Ra Lee, MD    82-31-787-2455    drmom@paran.com   
Principal Investigator: Jae-joon Yim, MD         
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Principal Investigator: Jae-Joon Yim, MD Seoul National University Hospital
  More Information

No publications provided

Responsible Party: Jae-Joon Yim, Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT01616745     History of Changes
Other Study ID Numbers: H-1103-057-355
Study First Received: March 25, 2012
Last Updated: June 11, 2012
Health Authority: South Korea: Korea Food and Drug Administration (KFDA)

Keywords provided by Seoul National University Hospital:
NTM Lung disease
NTM Lung disease patients enrolled in SNUH

Additional relevant MeSH terms:
Lung Diseases
Mycobacterium Infections
Respiratory Tract Diseases
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections

ClinicalTrials.gov processed this record on August 19, 2014